{"transactions":[{"id":730386,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T20:45:37.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":59000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":59000,"derivative":{"exercise_price":2.96,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":59000},"source":{"system":"sec-edgar","filing":"0001610717-26-000274","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000161071726000274/form4.xml","form_type":"4"}},{"id":730385,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T20:15:01.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":2340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 18, 2027 and the date of the 2027 Annual Meeting of Stockholders."}],"balance_after":2340,"derivative":{"exercise_price":2.02,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":2340},"source":{"system":"sec-edgar","filing":"0000905148-26-003045","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000090514826003045/form4.xml","form_type":"4"}},{"id":1102569,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T20:31:17.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":18700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 20, 2026 and the date of the 2026 Annual Meeting of Stockholders."}],"balance_after":18700,"derivative":{"exercise_price":0.47,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":18700},"source":{"system":"sec-edgar","filing":"0000905148-25-002245","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000090514825002245/form4.xml","form_type":"4"}},{"id":1111382,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:17:23.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2026 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":38000,"derivative":{"exercise_price":2.82,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001610717-25-000211","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000161071725000211/form4.xml","form_type":"4"}},{"id":1175370,"issuer":{"id":80946,"kind":"organization","name":"Gritstone bio, Inc.","symbol":"GRTS"},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-09T00:58:24.000Z","date":"2025-04-04","kind":"other","planned":false,"acquired":false,"shares":15942,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Issuer's Second Modified Plan of Reorganization pursuant to Chapter 11 of the Bankruptcy Code, which was confirmed by the United States Bankruptcy Court for the District of Delaware on April 3, 2025 and became effective on April 4, 2025, each share of the Issuer's common stock and options to purchase the Issuer's common stock outstanding prior to the Issuer's emergence from bankruptcy were cancelled for no value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":10.2,"expiration_date":"2029-09-11","underlying":"Common Stock","underlying_shares":15942},"source":{"system":"sec-edgar","filing":"0001415889-25-010438","document":"form4-04092025_120421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000141588925010438/form4-04092025_120421.xml","form_type":"4"}},{"id":1175369,"issuer":{"id":80946,"kind":"organization","name":"Gritstone bio, Inc.","symbol":"GRTS"},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-09T00:58:24.000Z","date":"2025-04-04","kind":"other","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Issuer's Second Modified Plan of Reorganization pursuant to Chapter 11 of the Bankruptcy Code, which was confirmed by the United States Bankruptcy Court for the District of Delaware on April 3, 2025 and became effective on April 4, 2025, each share of the Issuer's common stock and options to purchase the Issuer's common stock outstanding prior to the Issuer's emergence from bankruptcy were cancelled for no value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.66,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001415889-25-010438","document":"form4-04092025_120421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000141588925010438/form4-04092025_120421.xml","form_type":"4"}},{"id":1175368,"issuer":{"id":80946,"kind":"organization","name":"Gritstone bio, Inc.","symbol":"GRTS"},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-09T00:58:24.000Z","date":"2025-04-04","kind":"other","planned":false,"acquired":false,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Issuer's Second Modified Plan of Reorganization pursuant to Chapter 11 of the Bankruptcy Code, which was confirmed by the United States Bankruptcy Court for the District of Delaware on April 3, 2025 and became effective on April 4, 2025, each share of the Issuer's common stock and options to purchase the Issuer's common stock outstanding prior to the Issuer's emergence from bankruptcy were cancelled for no value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":9.86,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001415889-25-010438","document":"form4-04092025_120421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000141588925010438/form4-04092025_120421.xml","form_type":"4"}},{"id":1175367,"issuer":{"id":80946,"kind":"organization","name":"Gritstone bio, Inc.","symbol":"GRTS"},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stcok Option (right to buy)","published_at":"2025-04-09T00:58:24.000Z","date":"2025-04-04","kind":"other","planned":false,"acquired":false,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Issuer's Second Modified Plan of Reorganization pursuant to Chapter 11 of the Bankruptcy Code, which was confirmed by the United States Bankruptcy Court for the District of Delaware on April 3, 2025 and became effective on April 4, 2025, each share of the Issuer's common stock and options to purchase the Issuer's common stock outstanding prior to the Issuer's emergence from bankruptcy were cancelled for no value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.22,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001415889-25-010438","document":"form4-04092025_120421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000141588925010438/form4-04092025_120421.xml","form_type":"4"}},{"id":1175366,"issuer":{"id":80946,"kind":"organization","name":"Gritstone bio, Inc.","symbol":"GRTS"},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-09T00:58:24.000Z","date":"2025-04-04","kind":"other","planned":false,"acquired":false,"shares":51800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Issuer's Second Modified Plan of Reorganization pursuant to Chapter 11 of the Bankruptcy Code, which was confirmed by the United States Bankruptcy Court for the District of Delaware on April 3, 2025 and became effective on April 4, 2025, each share of the Issuer's common stock and options to purchase the Issuer's common stock outstanding prior to the Issuer's emergence from bankruptcy were cancelled for no value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option will vest and become exercisable on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":0.76,"expiration_date":"2034-06-16","underlying":"Common Stock","underlying_shares":51800},"source":{"system":"sec-edgar","filing":"0001415889-25-010438","document":"form4-04092025_120421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000141588925010438/form4-04092025_120421.xml","form_type":"4"}},{"id":1175365,"issuer":{"id":80946,"kind":"organization","name":"Gritstone bio, Inc.","symbol":"GRTS"},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-09T00:58:24.000Z","date":"2025-04-04","kind":"other","planned":false,"acquired":false,"shares":51800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Issuer's Second Modified Plan of Reorganization pursuant to Chapter 11 of the Bankruptcy Code, which was confirmed by the United States Bankruptcy Court for the District of Delaware on April 3, 2025 and became effective on April 4, 2025, each share of the Issuer's common stock and options to purchase the Issuer's common stock outstanding prior to the Issuer's emergence from bankruptcy were cancelled for no value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.19,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":51800},"source":{"system":"sec-edgar","filing":"0001415889-25-010438","document":"form4-04092025_120421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000141588925010438/form4-04092025_120421.xml","form_type":"4"}},{"id":1471910,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T21:04:33.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":18700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 20, 2025 and the date of the 2025 Annual Meeting of Stockholders."}],"balance_after":18700,"derivative":{"exercise_price":1.5,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":18700},"source":{"system":"sec-edgar","filing":"0000905148-24-001767","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000090514824001767/form4.xml","form_type":"4"}},{"id":1472997,"issuer":{"id":80946,"kind":"organization","name":"Gritstone bio, Inc.","symbol":"GRTS"},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T21:52:50.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":51800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through the applicable vesting date."}],"balance_after":51800,"derivative":{"exercise_price":0.76,"expiration_date":"2034-06-16","underlying":"Common Stock","underlying_shares":51800},"source":{"system":"sec-edgar","filing":"0001415889-24-017701","document":"form4-06202024_090646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000141588924017701/form4-06202024_090646.xml","form_type":"4"}},{"id":1511030,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-17T21:33:14.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2025 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":38000,"derivative":{"exercise_price":1.96,"expiration_date":"2034-05-14","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001610717-24-000244","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000161071724000244/form4.xml","form_type":"4"}},{"id":1845057,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-23T20:30:46.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 22, 2024 and the date of the 2024 Annual Meeting of Stockholders."}],"balance_after":14250,"derivative":{"exercise_price":1.62,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":14250},"source":{"system":"sec-edgar","filing":"0001140361-23-031189","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000114036123031189/form4.xml","form_type":"4"}},{"id":1847679,"issuer":{"id":80946,"kind":"organization","name":"Gritstone bio, Inc.","symbol":"GRTS"},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-21T20:52:31.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":51800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through the applicable vesting date."}],"balance_after":51800,"derivative":{"exercise_price":2.19,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":51800},"source":{"system":"sec-edgar","filing":"0000899243-23-016161","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000089924323016161/doc4.xml","form_type":"4"}},{"id":1851880,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T21:49:16.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2024 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.57,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001610717-23-000178","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000161071723000178/form4.xml","form_type":"4"}},{"id":1933846,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-31T23:56:04.000Z","date":"2023-03-29","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.55,"value":7750.0,"ownership":{"direct":true},"balance_after":5142,"source":{"system":"sec-edgar","filing":"0001140361-23-015503","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000114036123015503/form4.xml","form_type":"4"}},{"id":2221907,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T21:23:43.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 23, 2023 and the date of the 2023 Annual Meeting of Stockholders."}],"balance_after":14250,"derivative":{"exercise_price":4.77,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":14250},"source":{"system":"sec-edgar","filing":"0001567619-22-013367","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000156761922013367/doc1.xml","form_type":"4"}},{"id":2223986,"issuer":{"id":80946,"kind":"organization","name":"Gritstone bio, Inc.","symbol":"GRTS"},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-22T21:33:31.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through the applicable vesting date."}],"balance_after":19000,"derivative":{"exercise_price":2.22,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001567619-22-013258","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000156761922013258/doc1.xml","form_type":"4"}},{"id":2227415,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T20:04:56.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.72,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001567619-22-013070","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000156761922013070/doc1.xml","form_type":"4"}},{"id":2502492,"issuer":{"id":80946,"kind":"organization","name":"Gritstone bio, Inc.","symbol":"GRTS"},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-19T22:10:06.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through the applicable vesting date."}],"balance_after":19000,"derivative":{"exercise_price":9.86,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001567619-21-020865","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000156761921020865/doc1.xml","form_type":"4"}},{"id":2653251,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-28T22:13:53.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 24, 2022 and the date of the 2022 Annual Meeting of Stockholders."}],"balance_after":14250,"derivative":{"exercise_price":8.21,"expiration_date":"2031-06-23","underlying":"Common Stock","underlying_shares":14250},"source":{"system":"sec-edgar","filing":"0001567619-21-012668","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000156761921012668/doc1.xml","form_type":"4"}},{"id":2663360,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T22:44:36.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":7.13,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-21-012367","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000156761921012367/doc1.xml","form_type":"4"}},{"id":3102980,"issuer":{"id":80946,"kind":"organization","name":"Gritstone bio, Inc.","symbol":"GRTS"},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-22T21:34:50.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through the applicable vesting date."}],"balance_after":12500,"derivative":{"exercise_price":6.66,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001567619-20-012486","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000156761920012486/doc1.xml","form_type":"4"}},{"id":3106773,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-17T21:09:40.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2021 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":8.35,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-20-012301","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000156761920012301/doc1.xml","form_type":"4"}},{"id":3110410,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-15T21:37:29.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 11, 2021 and the date of the 2021 Annual Meeting of Stockholders."}],"balance_after":14250,"derivative":{"exercise_price":24.13,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":14250},"source":{"system":"sec-edgar","filing":"0001123292-20-000880","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000112329220000880/edgar.xml","form_type":"4"}},{"id":3414897,"issuer":{"id":80946,"kind":"organization","name":"Gritstone bio, Inc.","symbol":"GRTS"},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-13T20:19:37.000Z","date":"2019-09-12","kind":"grant","acquired":true,"shares":15942,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in substantially equal monthly installments for three years from the date of grant, subject to continued service through each applicable vesting date."}],"balance_after":15942,"derivative":{"exercise_price":10.2,"expiration_date":"2029-09-12","underlying":"Common Stock","underlying_shares":15942},"source":{"system":"sec-edgar","filing":"0001567619-19-018265","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000156761919018265/doc1.xml","form_type":"4"}},{"id":3481183,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-21T18:02:53.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2020 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":14000,"derivative":{"exercise_price":11.31,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001567619-19-013823","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000156761919013823/doc1.xml","form_type":"4"}},{"id":3487556,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-18T00:23:30.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on June 13, 2020."}],"balance_after":22000,"derivative":{"exercise_price":15.57,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001123292-19-000893","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000112329219000893/edgar.xml","form_type":"4"}},{"id":3542190,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36310,"kind":"person","name":"Jones Elaine V","position":1,"cik":"0001296907","reported_name":"Jones Elaine V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-03T00:00:01.000Z","date":"2019-05-01","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest on each monthly anniversary measured from May 1, 2019 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":28000,"derivative":{"exercise_price":9.35,"expiration_date":"2029-04-30","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001567619-19-009691","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296907/000156761919009691/doc1.xml","form_type":"4"}}]}